Platelet-derived short-chain polyphosphates enhance the inactivation of tissue factor pathway inhibitor by activated coagulation factor XI

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Puy, Cristina ^a,b   Tucker, Erik I ^a,c   Ivanov, Ivan S ^d   Gailani, David ^d   Smith, Stephanie A ^e   Morrissey, James H ^e   Gruber, András ^a,b,c   McCarty, Owen J T ^a,b,f  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Aronora Inc   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; POLYPHOSPHATE; SHORT CHAIN POLYPHOSPHATE; TISSUE FACTOR PATHWAY INHIBITOR; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 7A; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; PROTEIN BINDING; THROMBOPLASTIN; ZINC;

ARTICLE; CONTROLLED STUDY; FRACTIONATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR DYNAMICS; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; THROMBOCYTE;

BLOOD PLATELETS; FACTOR VIIA; FACTOR XIA; HUMANS; KINETICS; LIPOPROTEINS; POLYPHOSPHATES; PROTEIN BINDING; THROMBOPLASTIN; ZINC;

EID: 84992047587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165172     Document Type: Article

References (37)

1. Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost. 2009; 7 Suppl 1: 84-7. doi: 10.1111/ j.1538-7836.2009.03395.x PMID: 19630775
2. Kravtsov D V, Matafonov A, Tucker EI, Sun M-F, Walsh PN, Gruber A, et al. Factor XI contributes to thrombin generation in the absence of factor XII. Blood. 2009; 114: 452-8. doi: 10.1182/blood-2009-02-203604 PMID: 19351955
3. Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science. 1991; 253: 909-12. PMID: 1652157
4. Puy C, Tucker EI, Wong ZC, Gailani D, Smith SA, Choi SH, et al. Factor XII promotes blood coagulation independent of factor XI in the presence of long chain polyphosphate. J Thromb Haemost. 2013; 11: 1341-52. doi: 10.1111/jth.12295 PMID: 23659638
5. Whelihan MF, Orfeo T, Gissel MT, Mann KG. Coagulation procofactor activation by factor XIa. J Thromb Haemost. 2010; 8: 1532-9. doi: 10.1111/j.1538-7836.2010.03899.x PMID: 20456758
6. Matafonov A, Cheng Q, Geng Y, Verhamme IM, Umunakwe O, Tucker EI, et al. Evidence for factor IXindependent roles for factor XIa in blood coagulation. J Thromb Haemost. 2013; 11: 2118-27. doi: 10. 1111/jth.12435 PMID: 24152424
7. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011; 118: 6963-70. doi: 10.1182/blood-2011-07-368811 PMID: 21976677
8. Geng Y, Verhamme IM, Smith SB, Sun M-F, Matafonov A, Cheng Q, et al. The dimeric structure of factor XI and zymogen activation. Blood. 2013; 121: 3962-9. doi: 10.1182/blood-2012-12-473629 PMID: 23515926
9. Choi SH, Smith SA, Morrissey JH. Polyphosphate accelerates factor V activation by factor XIa. Thromb Haemost. 2015; 113: 599-604. doi: 10.1160/TH14-06-0515 PMID: 25338662
10. Wood JP, Bunce MW, Maroney SA, Tracy PB, Camire RM, Mast AE. Tissue factor pathway inhibitoralpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A. 2013; 110: 17838-43. doi: 10.1073/pnas.1310444110 PMID: 24127605
11. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989; 338: 518-20. doi: 10.1038/338518a0 PMID: 2927510
12. Petersen LC, Bjørn SE, Olsen OH, Nordfang O, Norris F, Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem. 1996; 235: 310-6. PMID: 8631347
13. Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood. 2005; 105: 2777-82. doi: 10.1182/blood-2004-09-3724 PMID: 15598816
14. Puy C, Tucker EI, Matafonov A, Cheng Q, Zientek KD, Gailani D, et al. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood. 2015; 125: 1488-96. doi: 10.1182/blood-2014-10-604587 PMID: 25587039
15. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA. National Academy of Sciences; 2006; 103: 903-908. doi: 10.1073/pnas.0507195103 PMID: 16410357
16. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010; 116: 4353-4359. doi: 10. 1182/blood-2010-01-266791 PMID: 20709905
17. Puy C, Rigg RA, McCarty OJT. The hemostatic role of factor XI. Thromb Res. 2016; 141: S8-S11. doi: 10.1016/S0049-3848(16)30354-1 PMID: 27207433
18. Geng Y, Verhamme IM, Smith SA, Cheng Q, Sun M, Sheehan JP, et al. Factor XI anion-binding sites are required for productive interactions with polyphosphate. J Thromb Haemost. 2013; 11: 2020-8. doi: 10.1111/jth.12414 PMID: 24118982
19. Zhu S, Travers RJ, Morrissey JH, Diamond SL. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow. Blood. 2015; 126: 1494-502. doi: 10.1182/blood-2015-04-641472 PMID: 26136249
20. Duchemin J, Pan-Petesch B, Arnaud B, Blouch M-T, Abgrall J-F. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost. 2008; 99: 767-73. doi: 10.1160/TH07-09-0581 PMID: 18392335
21. Aslan JE, Itakura A, Gertz JM, McCarty OJT. Platelet shape change and spreading. Methods Mol Biol. 2012; 788: 91-100. doi: 10.1007/978-1-61779-307-3-7 PMID: 22130702
22. Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 2007; 109: 1931-7. doi: 10.1182/ blood-2006-07-037283 PMID: 17082321
23. Mast AE, Broze GJ. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood. 1996; 87: 1845-50. PMID: 8634431
24. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 1988; 50: 803-13. PMID: 3413731
25. Donovan AJ, Kalkowski J, Smith SA, Morrissey JH, Liu Y. Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clotting. Biomacromolecules. 2014; 15: 3976-84. doi: 10.1021/bm501046t PMID: 25268994
26. Bock PE, Srinivasan KR, Shore JD. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Biochemistry. 1981; 20: 7258-66. PMID: 6797471
27. Mutch NJ, Waters EK, Morrissey JH. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation. J Thromb Haemost. 2012; 10: 2108-15. doi: 10.1111/j.1538-7836.2012.04890.x PMID: 22905925
28. Baglia FA, Gailani D, López JA, Walsh PN. Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI. J Biol Chem. 2004; 279: 45470-6. doi: 10.1074/jbc.M406727200 PMID: 15317813
29. Gailani D, Broze GJ. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood coagul Fibrinolysis. 1993; 4: 15-20. PMID: 8457645
30. Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun M-F, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood. 2010; 116: 3981-9. doi: 10.1182/blood-2010-02-270918 PMID: 20634381
31. Gruber A, Hanson SR. Factor XI-dependence of surface-and tissue factor-initiated thrombus propagation in primates. Blood. 2003; 102: 953-5. doi: 10.1182/blood-2003-01-0324 PMID: 12689935
32. Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, et al. Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis. N Engl J Med. 2014; 372: 232-40. doi: 10.1056/ NEJMoa1405760 PMID: 25482425
33. Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Nielsen L V, Johansen PB, et al. Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia. Proc Natl Acad Sci USA. 2012; 109: 3927-31. doi: 10.1073/pnas.1119858109 PMID: 22355108
34. Vincent LM, Tran S, Livaja R, Bensend TA, Milewicz DM, Dahlbäck B. Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIa. J Clin Invest. 2013; 123: 3777-87. doi: 10.1172/ JCI69091 PMID: 23979162
35. Pike GN, Cumming AM, Hay CRM, Bolton-Maggs PHB, Burthem J. Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency. Blood. 2015; 126: 397-405. doi: 10.1182/blood-2014-12-616565 PMID: 25911238
36. Zucker M, Seligsohn U, Salomon O, Wolberg AS. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost. 2014; 12: 1121-30. doi: 10.1111/jth.12600 PMID: 24815347
37. Wong PC, Quan ML, Watson CA, Crain EJ, Harpel MR, Rendina AR, et al. In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa. J Thromb Thrombolysis. 2015; 40: 416-23. doi: 10.1007/s11239-015-1258-7 PMID: 26249722